The Human Microbiome Sequencing Market is expected to grow at a 20.8% CAGR during the forecasting period of 2024-2031. The group of microbes that live on and in our bodies is known as the human microbiome. The human microbiota, a collective term for the billions of microorganisms that cover human tissues, includes bacteria, fungi, and viruses. The term "microbiome" refers to all of these microorganisms' genes. The human body has so many ...
Report ID: 1380 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 190
The Bio Imaging Technologies Market Size is valued at USD 22.5 Bn in 2023 and is predicted to reach USD 37.7 Bn by the year 2031 at an 6.8% CAGR during the forecast period for 2024-2031. Bio-imaging technologies are used to observe biological structures, functions, and processes at the cellular, tissue, or molecular level. These technologies enable scientists and medical professionals to obtain precise images of biological samples or living or...
Report ID: 2828 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 165
The Protein Expression Market Size is valued at USD 2.5 Bn in 2023 and is predicted to reach USD 4.6 Bn by the year 2031 at an 7.7% CAGR during the forecast period for 2024-2031. The technique of creating an artificial protein, known as a heterologous protein, involves introducing recombinant DNA into a host cell, a process that exemplifies the essential biological function of protein expression. This fundamental process is so critical that ev...
Report ID: 2823 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 165
Lateral Flow Assay Market Size is valued at USD 20.65 Bn in 2023 and is predicted to reach USD 24.45 Bn by the year 2031 at a 2.21% CAGR during the forecast period for 2024-2031. Immunochromatographic tests, known as lateral flow assays, can determine if a target analyte, such as a pathogen or a biomarker, is present or absent in people or animals. Due to increased usage in medical diagnostics, a rise in the occurrence of infectious disea...
Report ID: 2729 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
The Structural Biology & Molecular Modeling Technique Market Size is valued at USD 7.4 Bn in 2023 and is predicted to reach USD 22.3 Bn by the year 2031 at an 14.9% CAGR during the forecast period for 2024-2031. The global market for structural biology and molecular modeling techniques has become a vital component of the life sciences and biotechnology industries. This growth is driven by the increasing complexity of biological systems and...
Report ID: 2711 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 170
The Recombinant Cell Culture Supplements Market Size is valued at 388.35 million in 2023 and is predicted to reach 1008.85 million by the year 2031 at a 12.75% CAGR during the forecast period for 2024-2031. Rising demand for cell culture supplements, increased mergers and acquisitions to diversify the portfolio of recombinant cell culture supplements, and increased funding for biopharmaceutical product research and development in the life s...
Report ID: 1847 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The Recombinant Chemicals Market Size is valued at USD 2.87 billion in 2023 and is predicted to reach USD 4.67 billion by the year 2031 at a 6.4% CAGR during the forecast period for 2024-2031. Recombinant chemicals are products or substances that are generated using recombinant DNA technology, which involves combining DNA from multiple sources to create novel genetic combinations. Biotechnology frequently use this procedure to produce a wide r...
Report ID: 2663 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 170
The Global Cell-Based Assay Market Size is valued at 17.79 billion in 2023 and is predicted to reach 32.28 billion by the year 2031 at a 7.81% CAGR during the forecast period for 2024-2031. Due to factors such as the rising need for drug discovery, the increased requirement for biotechnology research, and the increasing prevalence of infectious diseases, cancer, autoimmune diseases, and genetic disorders, the market is expected to experie...
Report ID: 1793 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Pharmaceutical CRDMO Services Market Size is valued at USD 114.8 billion in 2023 and is predicted to reach USD 266.7 billion by the year 2031 at an 11.3% CAGR during the forecast period for 2024-2031. Pharmaceutical Contract Research, Development, and Manufacturing Organization (CRDMO) services provide a comprehensive and unified solution for drug development, encompassing research, development, and manufacturing. These services encompass the ...
Report ID: 2651 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
The Global CEACAM8 Antigen Gene Market Size is predicted to witness an 8.9% CAGR during the forecast period for 2024-2031. The CD66b (Cluster of Differentiation 66b) protein, called Antigen-Related Cell Adhesion Molecule 8 (CEACAM8), belongs to the CEA gene family. Cell adhesion, cell motility, and pathogen binding are its primary functions. A robust range of products, increasing investments by major market participants, a high prevalence...
Report ID: 1713 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Pharmaceuticals